Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study.

MLA

Griffiths, Elizabeth A., et al. “Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: REVEAL, a Prospective, Observational Study.” Health and Quality of Life Outcomes, vol. 22, no. 1, Aug. 2024, p. 62. EBSCOhost, https://doi.org/10.1186/s12955-024-02279-2.

APA

Griffiths, E. A., Min, J. S., Lee, W.-N., Yu, J. C., Patel, Y., Myren, K.-J., & Dingli, D. (2024). Patient-reported outcomes and daily activity assessed with a digital wearable device in patients with paroxysmal nocturnal hemoglobinuria treated with ravulizumab: REVEAL, a prospective, observational study. Health and Quality of Life Outcomes, 22(1), 62. https://doi.org/10.1186/s12955-024-02279-2

Chicago

Griffiths, Elizabeth A, Jae S Min, Wei-Nchih Lee, Jeffrey C Yu, Yogesh Patel, Karl-Johan Myren, and David Dingli. 2024. “Patient-Reported Outcomes and Daily Activity Assessed with a Digital Wearable Device in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: REVEAL, a Prospective, Observational Study.” Health and Quality of Life Outcomes 22 (1): 62. doi:10.1186/s12955-024-02279-2.